EXAGEN INC. Operating Income

Quick Answer

EXAGEN INC. reported Operating Income of -$14.07 million for fiscal year 2025.

EXAGEN INC. Operating Income — Annual History

Fiscal Year Operating Income YoY Change
2025 -$14.07M -3.2%
2024 -$13.64M +40.3%
2023 -$22.84M +50.4%
2022 -$46.05M -91.3%
2021 -$24.07M -58.5%
2020 -$15.19M -63.3%
2019 -$9.30M -90.6%
2018 -$4.88M

Quarterly Operating Income

Quarter Ending Operating Income YoY QoQ
September 30, 2025 -$3.10M +33.5% -17.9%
June 30, 2025 -$2.63M -1.7% +21.8%
March 31, 2025 -$3.37M -12.1% +27.8%
September 30, 2024 -$4.66M +8.0% -80.2%
June 30, 2024 -$2.59M +47.4% +13.9%
March 31, 2024 -$3.00M +61.0% +40.8%
September 30, 2023 -$5.07M +35.2% -3.1%
June 30, 2023 -$4.92M +65.1% +36.2%
  • EXAGEN INC. showed a decrease of -3.2% in Operating Income compared to the prior fiscal year.
  • Over the 2018–2025 period, EXAGEN INC.’s operating income has declined by 188.3% (from -$4.88 million to -$14.07 million).
  • The most recent figure is from EXAGEN INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment